These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Wong GY; Gavva NR Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372 [TBL] [Abstract][Full Text] [Related]
25. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist. Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134 [TBL] [Abstract][Full Text] [Related]
26. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Szallasi A; Cortright DN; Blum CA; Eid SR Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of phenylpropanamides as novel transient receptor potential vanilloid 1 antagonists. Li FN; Kim NJ; Nam YH; Kim SH; Seo SY; Jeong YS; Kim SY; Park YH; Suh YG Arch Pharm Res; 2009 Sep; 32(9):1201-10. PubMed ID: 19784574 [TBL] [Abstract][Full Text] [Related]
28. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands. Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845 [TBL] [Abstract][Full Text] [Related]
29. Ion channel modulators: new targets and new indications for old targets. Priest B; Kaczorowski GJ; Garcia ML Curr Opin Drug Discov Devel; 2006 Sep; 9(5):587-94. PubMed ID: 17002219 [TBL] [Abstract][Full Text] [Related]
30. Analgesic dipeptides. VI.: Synthesis and structure-activity relationships of N-terminal modified analogues of the analgesic compounds H-Xaa-Trp(Nps)-OMe (Xaa=Lys, Orn, Arg). García-López MT; González-Muñiz R; Harto JR; Molinero MT; del Río J Arch Pharm (Weinheim); 1989 Mar; 322(3):145-52. PubMed ID: 2751408 [TBL] [Abstract][Full Text] [Related]
31. ThermoTRP channels as modular proteins with allosteric gating. Latorre R; Brauchi S; Orta G; Zaelzer C; Vargas G Cell Calcium; 2007; 42(4-5):427-38. PubMed ID: 17499848 [TBL] [Abstract][Full Text] [Related]
32. Role of TRPV1 receptors in descending modulation of pain. Palazzo E; Rossi F; Maione S Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659 [TBL] [Abstract][Full Text] [Related]
33. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068 [TBL] [Abstract][Full Text] [Related]
34. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903 [TBL] [Abstract][Full Text] [Related]
35. Hot receptors in the brain. Steenland HW; Ko SW; Wu LJ; Zhuo M Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351 [TBL] [Abstract][Full Text] [Related]
36. Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. Wang HL; Katon J; Balan C; Bannon AW; Bernard C; Doherty EM; Dominguez C; Gavva NR; Gore V; Ma V; Nishimura N; Surapaneni S; Tang P; Tamir R; Thiel O; Treanor JJ; Norman MH J Med Chem; 2007 Jul; 50(15):3528-39. PubMed ID: 17585751 [TBL] [Abstract][Full Text] [Related]